» Articles » PMID: 15591452

PGD for Autosomal Dominant Polycystic Kidney Disease Type 1

Overview
Journal Mol Hum Reprod
Date 2004 Dec 14
PMID 15591452
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is primarily characterized by renal cysts and progression to renal failure. It is a genetically heterogeneous disease, with mutations in the PKD1 gene accounting for the majority of cases. Direct mutation detection for PKD1-linked ADPKD or type 1 is complicated by the large size and complex genomic structure of PKD1. This paper describes a microsatellite marker-based assay for PGD in couples at risk of transmitting ADPKD type 1. During PGD, genetic analysis is carried out on single blastomeres biopsied from preimplantation embryos obtained after IVF, and only embryos unaffected by the disease under investigation are selected for transfer. Single-cell genetic analysis relied on a fluorescent duplex-PCR of linked polymorphic markers followed by fragment length determination on an automated sequencer. The co-amplification of the intragenic KG8 and the extragenic D16S291 marker at the single-cell level was evaluated in pre-clinical tests on lymphoblasts and research blastomeres. The developed assay proved to be efficient (96.1% amplification) and accurate (1.4% allele drop-out and 4.3% contamination), and can be applied in all informative ADPKD type 1 couples. From five clinical cycles carried out for three couples, two pregnancies ensued, resulting in the birth of two healthy children.

Citing Articles

Birth of two healthy girls following preimplantation genetic diagnosis and gestational surrogacy in a rapidly progressive autosomal dominant polycystic kidney disease case using tolvaptan.

Peces R, Mena R, Peces C, Cuesta E, Lapunzina P, Selgas R Clin Kidney J. 2021; 14(8):1987-1989.

PMID: 34345424 PMC: 8323138. DOI: 10.1093/ckj/sfab082.


A comprehensive PGT-M strategy for ADPKD patients with de novo PKD1 mutations using affected embryo or gametes as proband.

Wang Y, Zhai F, Guan S, Yan Z, Zhu X, Kuo Y J Assist Reprod Genet. 2021; 38(9):2425-2434.

PMID: 33939064 PMC: 8490604. DOI: 10.1007/s10815-021-02188-z.


The fertility willingness and acceptability of preimplantation genetic testing in Chinese patients with autosomal dominant polycystic kidney disease.

Sun M, Xue C, Lu Y, Ma Y, Pan T, Wang X BMC Nephrol. 2020; 21(1):147.

PMID: 32334565 PMC: 7183678. DOI: 10.1186/s12882-020-01785-x.


Heterozygosity analysis of polycystic kidney disease 1 gene microsatellite markers for linkage analysis of autosomal dominant polycystic kidney disease type 1 in the Iranian population.

Fatehi R, Khosravi S, Abedi M, Salehi R, Gheisari Y J Res Med Sci. 2017; 22:102.

PMID: 29026418 PMC: 5629830. DOI: 10.4103/jrms.JRMS_136_17.


Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease.

De Rechter S, Kringen J, Janssens P, Liebau M, Devriendt K, Levtchenko E PLoS One. 2017; 12(9):e0185779.

PMID: 28961265 PMC: 5621697. DOI: 10.1371/journal.pone.0185779.